Heartflow HTFL
NASDAQ HTFL
$49.83 -0.09 (-0.18%)
At close: Sep 29, 2026 · 4:00 PM EDT

Heartflow (HTFL) EBITDA Margin (2024 - 2025)

Updated

Heartflow (HTFL) posted EBITDA Margin of -33.34% for Q4 2025, up 8.02 percentage points from -41.36% a year earlier but down 3.52 percentage points from the prior quarter.

Analysis

Heartflow (HTFL) EBITDA Margin (2024 - 2025) Analysis & Trends

For FY2025, Heartflow's EBITDA Margin came in at -33.30%, up 11.10 percentage points from FY2024.

  • In prior years, Heartflow's EBITDA Margin was -44.40% in FY2024 (+33.80 pp) and -78.20% in FY2023.
  • Quarterly EBITDA Margin has run from a low of -41.36% in Q4 2024 to a high of -29.81% in Q3 2025 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn 24.20%
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn 21.86%
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn 28.51%
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn 41.08%
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn 25.55%
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn 29.67%
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn 28.17%
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn 24.62%
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn 31.93%
10 Heartflow 4.33 Bn 4.08 Bn 53.19 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -33.34%
Sep 30, 2025 -29.81%
Dec 31, 2024 -41.36%
Sep 30, 2024 -41.11%
API Access

Heartflow EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=HTFL&period=max&api_key=YOUR_API_KEY